If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

A novel biodegradable gel delivers Parkinson’s medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. The corresponding study was published in Drug ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for daily pills. Scientists from the University ...

A new initiative is set to explore the potential of repurposing existing medications to combat the symptoms of both Alzheimer’s and Parkinson’s diseases, aiming to accelerate the discovery of novel ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...